
Brainsway Ltd. BWAY
$ 15.29
-6.31%
Quarterly report 2025-Q2
added 05-13-2026
Brainsway Ltd. Total Liabilities 2011-2026 | BWAY
Annual Total Liabilities Brainsway Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 14.4 M | 14.5 M | 16.6 M | 14.3 M | 9.68 M | 9.35 M | 10.2 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.6 M | 9.35 M | 12.7 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 17.26 | -7.0 % | $ 181 M | ||
|
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
4.11 M | $ 1.34 | -17.79 % | $ 1.78 M | ||
|
Fulgent Genetics
FLGT
|
90.8 M | $ 15.78 | -2.53 % | $ 477 M | ||
|
Agilent Technologies
A
|
5.32 B | $ 112.09 | -1.02 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
108 M | $ 19.05 | 0.9 % | $ 552 M | ||
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
2.7 B | $ 139.97 | -2.28 % | $ 22.3 B | ||
|
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
11.5 M | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
110 M | $ 19.83 | -3.22 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
1.14 B | $ 94.74 | -2.0 % | $ 6.39 B | ||
|
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
1.52 B | $ 419.82 | 0.16 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
3.74 B | $ 1 043.89 | 0.19 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
339 M | $ 3.6 | -0.69 % | $ 333 M | ||
|
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
523 M | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
121 M | $ 18.46 | -2.48 % | $ 413 M | ||
|
Charles River Laboratories International
CRL
|
3.92 B | $ 157.18 | -1.33 % | $ 7.79 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
689 M | $ 186.22 | -5.43 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
16 B | $ 25.27 | -0.94 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
2.11 B | $ 92.95 | -5.79 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
65.2 M | $ 5.73 | -1.55 % | $ 239 M | ||
|
Personalis
PSNL
|
73 M | $ 6.47 | -3.64 % | $ 577 M | ||
|
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
7.35 B | $ 117.95 | 0.73 % | $ 9.73 B | ||
|
Soleno Therapeutics
SLNO
|
114 M | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
169 M | $ 49.3 | -6.89 % | $ 2.95 B | ||
|
Biomerica
BMRA
|
1.84 M | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 251.18 | -1.12 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
28.7 B | $ 439.31 | -1.97 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
138 M | $ 0.57 | -1.49 % | $ 205 M | ||
|
Celcuity
CELC
|
366 M | $ 134.9 | 0.13 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
2.52 B | $ 331.34 | -0.56 % | $ 19.7 B | ||
|
Neogen Corporation
NEOG
|
1.37 B | $ 8.27 | -1.9 % | $ 1.79 B |